English 
Español
Validation of a cell proliferation assay to assess the potency of a Dialyzable Leucocyte Extract intended for batch release.
Related Articles
-
UDIBI
Published: September 20, 2019 Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract...
-
UDIBI
November 8, 22 Altered neutrophil-to-lymphocyte ratio in sepsis secondary to canine parvoviral enteritis treated with and without an immunomodulator...
-
UDIBI
Quality attributes of partially hydrolyzed collagen in a liquid formulation used for skin care. SHOW MORE
-
UDIBI
Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point...
-
UDIBI
Colloids and Surfaces A: Physicochemical and Engineering Aspects. Structural and physicochemical characteristics of one-step PAMAM dendrimeric nanoparticles. SHOW MORE
-
UDIBI
SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library SHOW MORE
-
UDIBI
Published : March 2021 Poor survival in COVID-19 associated with Lymphopenia and Higher Neutrophile-Lymphocyte ratio More information
-
UDIBI
Characterization of a Complex Mixture of Immunomodulator Peptides Obtained from Autologous Urine. SHOW MORE
